awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
1471-2407-11-493
1471-2407-11-493
http://dx.doi.org/10.1186/1471-2407-11-493
A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.
P356
Q34082057-672E1792-8D23-4937-8D54-BC8BE23249C7
P356
1471-2407-11-493
http://dx.doi.org/10.1186/1471-2407-11-493